Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
, 1. Question 1
A newly certified family nurse practitioner (FNP) is preparing to
prescribe medications independently in a state where nurse
practitioners have full prescriptive authority. Which action best
demonstrates the APRN's responsibility when initiating
pharmacotherapy?
A. Select the medication based primarily on its FDA approval status
B. Prescribe the medication after confirming the diagnosis and
evaluating patient-specific risks, benefits, and alternatives
C. Use the medication most frequently prescribed by colleagues in the
practice
D. Defer all medication counseling to the dispensing pharmacist
Correct Answer:
B.
Rationale:
Safe prescribing requires the APRN to integrate the patient's diagnosis,
medical history, allergies, current medications, comorbidities,
contraindications, expected benefits, potential harms, and available
alternatives. FDA-approved labeling provides important safety and
efficacy information, but appropriate prescribing also requires
individualized clinical judgment. Pharmacists are valuable members of
the interprofessional team but do not replace the prescriber's
responsibility for appropriate prescribing and patient education.
2. Question 2
,An adult patient presents for evaluation of a newly diagnosed chronic
condition. The patient takes six prescription medications, two over-the-
counter products, and several herbal supplements. Before initiating a
new prescription, which action should the APRN prioritize?
A. Review only the patient's prescription medications
B. Ask the patient to discontinue all nonprescription products
C. Complete a comprehensive medication reconciliation, including
supplements and nonprescription drugs
D. Prescribe the new medication and reassess for interactions at the
next visit
Correct Answer:
C.
Rationale:
A complete medication reconciliation should include prescription drugs,
over-the-counter medications, vitamins, minerals, and herbal products.
This process can identify duplicate therapy, drug-drug interactions,
drug-disease interactions, and potentially harmful combinations before
a new medication is prescribed. Automatically discontinuing
nonprescription products is not appropriate without assessing their
indication and risk.
3. Question 3
A patient asks an APRN why a prescribed medication is being used for a
condition that is not listed among the medication's FDA-approved
indications. Which response is most appropriate?
A. "The medication is experimental and therefore cannot legally be
prescribed."
B. "The FDA prohibits prescribing medications for conditions outside
, their approved indications."
C. "Clinicians may prescribe medications off-label when professional
judgment supports their use, but the evidence, risks, benefits, and
alternatives should be considered."
D. "Off-label prescribing is permitted only when no FDA-approved
medication exists."
Correct Answer:
C.
Rationale:
Off-label prescribing is a recognized component of clinical practice in
which an approved medication is used in a manner not specifically
included in its FDA-approved labeling. The prescriber remains
responsible for evaluating available evidence, clinical appropriateness,
risks, benefits, and alternatives and for communicating relevant
information to the patient. Off-label use is not inherently experimental
or prohibited.
4. Question 4
An APRN is considering initiating a medication with a boxed warning for
a patient with multiple chronic conditions. Which approach is most
appropriate?
A. Avoid the medication automatically because a boxed warning means
the drug is contraindicated
B. Prescribe the medication without discussion because boxed warnings
apply only to pharmacists
C. Review the boxed warning, determine whether the patient's clinical
situation increases risk, and discuss the benefit-risk balance with the
patient
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
, 1. Question 1
A newly certified family nurse practitioner (FNP) is preparing to
prescribe medications independently in a state where nurse
practitioners have full prescriptive authority. Which action best
demonstrates the APRN's responsibility when initiating
pharmacotherapy?
A. Select the medication based primarily on its FDA approval status
B. Prescribe the medication after confirming the diagnosis and
evaluating patient-specific risks, benefits, and alternatives
C. Use the medication most frequently prescribed by colleagues in the
practice
D. Defer all medication counseling to the dispensing pharmacist
Correct Answer:
B.
Rationale:
Safe prescribing requires the APRN to integrate the patient's diagnosis,
medical history, allergies, current medications, comorbidities,
contraindications, expected benefits, potential harms, and available
alternatives. FDA-approved labeling provides important safety and
efficacy information, but appropriate prescribing also requires
individualized clinical judgment. Pharmacists are valuable members of
the interprofessional team but do not replace the prescriber's
responsibility for appropriate prescribing and patient education.
2. Question 2
,An adult patient presents for evaluation of a newly diagnosed chronic
condition. The patient takes six prescription medications, two over-the-
counter products, and several herbal supplements. Before initiating a
new prescription, which action should the APRN prioritize?
A. Review only the patient's prescription medications
B. Ask the patient to discontinue all nonprescription products
C. Complete a comprehensive medication reconciliation, including
supplements and nonprescription drugs
D. Prescribe the new medication and reassess for interactions at the
next visit
Correct Answer:
C.
Rationale:
A complete medication reconciliation should include prescription drugs,
over-the-counter medications, vitamins, minerals, and herbal products.
This process can identify duplicate therapy, drug-drug interactions,
drug-disease interactions, and potentially harmful combinations before
a new medication is prescribed. Automatically discontinuing
nonprescription products is not appropriate without assessing their
indication and risk.
3. Question 3
A patient asks an APRN why a prescribed medication is being used for a
condition that is not listed among the medication's FDA-approved
indications. Which response is most appropriate?
A. "The medication is experimental and therefore cannot legally be
prescribed."
B. "The FDA prohibits prescribing medications for conditions outside
, their approved indications."
C. "Clinicians may prescribe medications off-label when professional
judgment supports their use, but the evidence, risks, benefits, and
alternatives should be considered."
D. "Off-label prescribing is permitted only when no FDA-approved
medication exists."
Correct Answer:
C.
Rationale:
Off-label prescribing is a recognized component of clinical practice in
which an approved medication is used in a manner not specifically
included in its FDA-approved labeling. The prescriber remains
responsible for evaluating available evidence, clinical appropriateness,
risks, benefits, and alternatives and for communicating relevant
information to the patient. Off-label use is not inherently experimental
or prohibited.
4. Question 4
An APRN is considering initiating a medication with a boxed warning for
a patient with multiple chronic conditions. Which approach is most
appropriate?
A. Avoid the medication automatically because a boxed warning means
the drug is contraindicated
B. Prescribe the medication without discussion because boxed warnings
apply only to pharmacists
C. Review the boxed warning, determine whether the patient's clinical
situation increases risk, and discuss the benefit-risk balance with the
patient
